YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
2 Volatile Stocks to Consider Right Now and 1 We Find Risky Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the…
1 Momentum Stock to Research Further and 2 We Turn Down The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or imp…
3 Healthcare Stocks That Concern Us Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising…
Fortrea Holdings has delivered a sharp share price move over the past year, which puts the focus squarely on whether that jump lines up with the cash the business can generate. With the stock now reflecting both recent momentum and fresh d…
3 Cash-Producing Stocks That Concern Us A company that generates cash isn't automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Not all companies are created equal, and Stoc…
2 Small-Cap Stocks to Research Further and 1 Facing Challenges Investors looking for hidden gems should keep an eye on small-cap stocks because they're frequently overlooked by Wall Street. Many opportunities exist in this part of the mark…
2 of Wall Street's Favorite Stocks to Target This Week and 1 Facing Challenges Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it's important to remain skeptical…
Q2 Earnings Review: Drug Development Inputs & Services Stocks Led by Azenta (NASDAQ:AZTA) As the Q2 earnings season wraps, let's dig into this quarter's best and worst performers in the drug development inputs & services industry, includin…
Check out the companies making headlines this week: SAIC (NASDAQ:SAIC): Government IT services provider Science Applications International Corporation (NASDAQ:SAIC) rose by 5.5% on Monday after the company reported second-quarter CY2026 fi…
Stocks making big moves yesterday: Limbach, FuelCell Energy, Ollie's, Fortrea, and G-III Check out the companies making headlines yesterday: Limbach (NASDAQ:LMB): Building systems company Limbach (NASDAQ:LMB) rose by 8.1% on Wednesday afte…
Drug Development Inputs & Services Stocks Q2 Recap: Benchmarking Medpace (NASDAQ:MEDP) As the Q2 earnings season comes to a close, it's time to take stock of this quarter's best and worst performers in the drug development inputs & service…
Well-known pharmaceutical companies such as Merck and Pfizer typically manage this complex process in house. Medpace Holdings which targets oncology, metabolic, cardiology, central nervous system, and anti-infective therapies, raised its 2…
Investment management company Curreen Capital released its second-quarter 2026 Investor letter. A copy of the letter can be downloaded here. In the second quarter, the fund returned 22.26% compared to 15.20% for the S&P 500 Index. The perf…
ICON Public Limited Company ICLR presents a mixed investment case. The stock trades below several key benchmarks, while new business awards and backlog point to healthier commercial demand. That opportunity is tempered by weaker earnings e…
IQVIA Holdings Inc. IQV shares climbed 13% in a week as investors weighed better-than-expected quarterly results, stronger bookings and a raised full-year outlook. The move reflects improving operating momentum, but its durability depends…
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Fortrea Holdings Inc. (FTRE) and argenex SE (ARGX). But which of these two companies is the best option for those looking for undervalued stocks? Let…
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Fortrea Holdings Inc. (FTRE) and argenex SE (ARGX). But which of these two companies is the best option for those looking for undervalued stocks? Let…
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 31st: Fortrea Holdings Inc. FTRE: This company, which is a provider of clinical development and patient access solutions to the l…
Earnings Call Insights: Fortrea Holdings Inc. (FTRE) Q2 2026 MANAGEMENT VIEW * "Today, we are pleased to report another quarter of steady progress on that journey, improving our full year revenue and adjusted EBITDA guidance." (CEO & Direc…
Key Points Interested in Fortrea Holdings Inc.? Here are five stocks we like better. Fortrea raised its 2026 outlook after reporting second-quarter revenue of $678.2 million and adjusted EBITDA of $58.7 million. The company now expects ful…
Fortrea Holdings Inc. (FTRE) came out with quarterly earnings of $0.23 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.19 per share a year ago. These figures are adjusted for non-recurrin…
Four consecutive quarters of execution to drive commercial, operational and financial excellence Increases full-year guidance Highlights For the three months ended June 30, 2026: Revenues of $678.2 millionBook-to-bill ratio of 1.06x, resul…
Quant rankings for the upcoming earnings calendar show strength concentrated across information technology, energy, and materials, while weakness is more pronounced in industrials, financials, and real estate. A total of 966 companies are…
3 Reasons to Sell FTRE and 1 Stock to Buy Instead Fortrea trades at $17.93 and has moved in lockstep with the market. Its shares have returned 13.3% over the last six months while the S&P 500 has gained 11.4%. Is there a buying opportunity…
A strong stock as of late has been Royalty Pharma (RPRX). Shares have been marching higher, with the stock up 4.8% over the past month. The stock hit a new 52-week high of $58.84 in the previous session. Royalty Pharma has gained 50% since…
For Immediate Release Chicago, IL – July 10, 2026 – Today, Zacks Investment Ideas feature highlights Health Care Sector ETF XLV, Biotech ETF XBI, Eli Lilly (LLY), Exelixis EXEL, PTC Therapeutics PTCT, Fortrea Holdings FTRE and Illumina ILM…
Agilent Technologies A shares have lost 5.2% in the year-to-date period, underperforming the Zacks Medical industry's 2.8% growth. The dip reflects cautious laboratory spending and a challenging macroeconomic environment. However, Agilent…
Markets have broadly put up strong numbers this year, especially since the late-March stumble that followed the escalation of conflict in Iran. The rally has been led by semiconductors, unsurprisingly tied to the ongoing AI boom. But that…
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Fortrea Holdings Inc. (FTRE) and argenex SE (ARGX). But which of these two stocks offers value investors a better bang for thei…
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Diversified Energy Company PLC DEC: This energy company, which is focused on natural gas and liquids production, transport, marketing and well retirement, has seen th…
1 Russell 2000 Stock Worth Your Attention and 2 That Underwhelm The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these b…
3 Overrated Stocks Walking a Fine Line The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial p…
Stocks making big moves yesterday: Fortrea, Kura Sushi, Energizer, Bath and Body Works, and Robinhood Check out the companies making headlines yesterday: Fortrea (NASDAQ:FTRE): Clinical research company Fortrea Holdings (NASDAQ:FTRE) rose…
3 Unpopular Stocks We're Skeptical Of Wall Street's bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps del…
1 Unprofitable Stock to Research Further and 2 We Question Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk run…
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at IQVIA (NYSE:IQV) and the best and worst performers in the drug development inputs…